DE4107334A1 - Serum-diagnoseverfahren und dafuer geeigneter diagnosesatz - Google Patents

Serum-diagnoseverfahren und dafuer geeigneter diagnosesatz

Info

Publication number
DE4107334A1
DE4107334A1 DE4107334A DE4107334A DE4107334A1 DE 4107334 A1 DE4107334 A1 DE 4107334A1 DE 4107334 A DE4107334 A DE 4107334A DE 4107334 A DE4107334 A DE 4107334A DE 4107334 A1 DE4107334 A1 DE 4107334A1
Authority
DE
Germany
Prior art keywords
serum
cancer
serum diagnostic
cytochrome
histones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4107334A
Other languages
German (de)
English (en)
Inventor
Shuichi Hashizume
Masatoshi Kato
Masanori Kamei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga and Co Ltd
Original Assignee
Morinaga and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5723690A external-priority patent/JPH03257367A/ja
Priority claimed from JP13914690A external-priority patent/JPH0432766A/ja
Application filed by Morinaga and Co Ltd filed Critical Morinaga and Co Ltd
Publication of DE4107334A1 publication Critical patent/DE4107334A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/5752—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/80—Cytochromes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE4107334A 1990-03-08 1991-03-07 Serum-diagnoseverfahren und dafuer geeigneter diagnosesatz Withdrawn DE4107334A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5723690A JPH03257367A (ja) 1990-03-08 1990-03-08 血清診断法
JP13914690A JPH0432766A (ja) 1990-05-29 1990-05-29 血清診断法

Publications (1)

Publication Number Publication Date
DE4107334A1 true DE4107334A1 (de) 1991-09-12

Family

ID=26398252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4107334A Withdrawn DE4107334A1 (de) 1990-03-08 1991-03-07 Serum-diagnoseverfahren und dafuer geeigneter diagnosesatz

Country Status (4)

Country Link
KR (1) KR910017189A (OSRAM)
DE (1) DE4107334A1 (OSRAM)
FR (1) FR2659449A1 (OSRAM)
GB (1) GB2241782B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229328A4 (en) * 1999-11-08 2005-02-23 Eisai Co Ltd METHOD OF DETECTING CELL DEATH, AND DETECTION REAGENT

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) * 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
US7138239B2 (en) 2001-05-09 2006-11-21 Eisai Co., Ltd. Method and reagent for testing for multiple organ failure in SIRS by cytochrome C measurement
EP1501869A4 (en) * 2001-08-03 2006-01-11 Univ Virginia HISTONE H2B PHOSPHORYLEE AS A MARKER FOR APOPTOSIS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906819A (en) * 1958-04-28 1962-09-26 Masaka Matsubara Parenteral solution for diagnostic test of cancer and a process of preparing same
DE3737274A1 (de) * 1987-11-03 1989-06-01 Rusch Volker Verwendung von reinem h2a- und/oder h2b-histon als wirksubstanz zur herstellung von arzneimitteln
AU2800389A (en) * 1987-12-02 1989-07-05 Regents Of The University Of California, The Aids-related anti-t-cell antibody test
JP2675117B2 (ja) * 1988-05-13 1997-11-12 森永製菓株式会社 がんの血清測定法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229328A4 (en) * 1999-11-08 2005-02-23 Eisai Co Ltd METHOD OF DETECTING CELL DEATH, AND DETECTION REAGENT

Also Published As

Publication number Publication date
GB2241782B (en) 1993-12-08
GB9104915D0 (en) 1991-04-24
KR910017189A (ko) 1991-11-05
GB2241782A (en) 1991-09-11
FR2659449A1 (OSRAM) 1991-09-13

Similar Documents

Publication Publication Date Title
DE2654723C2 (de) Magnetischer Festphasenträger für immunologische Bestimmungen sowie ein Verfahren zu dessen Herstellung
DE3854194T2 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
DE68918103T2 (de) Verfahren zur überwachung des kollagenabbaus.
DE3209149A1 (de) Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
DE3855890T2 (de) Verfahren zur herstellung von imunodiagnose-mitteln
EP1318405B1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE69821604T2 (de) Diagnose von epithelzellabnormitäten
DE2952478A1 (de) Verfahren und mittel zur immunologischen bestimmung von enzymen
EP0974841B1 (de) Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind
DE69601922T2 (de) Verfahren zur hochempfindlichen dosierung von herztroponin - i
WO1992002558A1 (de) Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikörpern
DE69204718T2 (de) CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit.
DE69723163T2 (de) Verfahren und Testsatz zur in vitro Bestätigung der Diagnose von Bauchkrankheit
DE3879085T2 (de) Snrnp-a-antigen und fragmente davon.
DE19920704C1 (de) Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
WO2003048778A1 (de) Verfahren zur diagnose von sepsis unter bestimmung von s100b
DE3887596T2 (de) Antikörper zum Propeptid des Prokollagen-III und seine Benutzung in einem Analyseverfahren.
EP0267355B1 (de) Verfahren zum Identifizieren gewebstypischer, unlöslicher Cytoskelettproteine
DE2804940A1 (de) Verfahren zur herstellung antigener substanzen und nachweismaterial
DE4107334A1 (de) Serum-diagnoseverfahren und dafuer geeigneter diagnosesatz
DE60035267T2 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
EP0443599A2 (de) Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstellung sowie ihre Verwendung
WO2003048777A1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
DE112022000500T5 (de) Enzym-fluoreszenz-testsatz für komplementaktiviertes c1s sowie ein testverfahren und dessen anwendung
EP0267356B1 (de) Verfahren und Testelement zum Auffinden von Zelläsionen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee